Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial)

Background The aim of colonic stenting with self-expandable metallic stents in neoplastic colon obstruction is to avoid emergency surgery and thus potentially reduce morbidity, mortality, and need for a stoma. Concern has been raised, however, about the effect of colonic stenting on short-term compl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical endoscopy 2017-08, Vol.31 (8), p.3297-3305
Hauptverfasser: Arezzo, Alberto, Balague, Carmen, Targarona, Eduardo, Borghi, Felice, Giraudo, Giorgio, Ghezzo, Luigi, Arroyo, Antonio, Sola-Vera, Javier, De Paolis, Paolo, Bossotti, Maurizio, Bannone, Elisa, Forcignanò, Edoardo, Bonino, Marco Augusto, Passera, Roberto, Morino, Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The aim of colonic stenting with self-expandable metallic stents in neoplastic colon obstruction is to avoid emergency surgery and thus potentially reduce morbidity, mortality, and need for a stoma. Concern has been raised, however, about the effect of colonic stenting on short-term complications and long-term survival. We compared morbidity rates after colonic stenting as a bridge to surgery (SBTS) versus emergency surgery (ES) in the management of left-sided malignant large-bowel obstruction. Methods This multicentre randomised controlled trial was designed with the endorsement of the European Association for Endoscopic Surgery. The study population was consecutive patients with acute, symptomatic malignant left-sided large-bowel obstruction localised between the splenic flexure and 15 cm from the anal margin. The primary outcome was overall morbidity within 60 days after surgery. Results Between March 2008 and November 2015, 144 patients were randomly assigned to undergo either SBTS or ES; 29/144 (13.9%) were excluded post-randomisation mainly because of wrong diagnosis at computed tomography examination. The remaining 115 patients (SBTS n  = 56, ES n  = 59) were deemed eligible for analysis. The complications rate within 60 days was 51.8% in the SBTS group and 57.6% in the ES group ( p  = 0.529). Although long-term follow-up is still ongoing, no statistically significant difference in 3-year overall survival ( p  = 0.998) and progression-free survival rates between the groups has been observed ( p  = 0.893). Eleven patients in the SBTS group and 23 in the ES group received a stoma ( p  = 0.031), with a reversal rate of 30% so far. Conclusions Our findings indicate that the two treatment strategies are equivalent. No difference in oncologic outcome was found at a median follow-up of 36 months. The significantly lower stoma rate noted in the SBTS group argues in favour of the SBTS procedure when performed in expert hands.
ISSN:0930-2794
1432-2218
DOI:10.1007/s00464-016-5362-3